TRUE TEST empl 10 x 3 pce
7680566880051
CH-56688
V04CL
14.03.0.
1 / 3
google
Details
- Product number
- 5668802
- CPT
- -
- Packaging group
- 10 x 3
- Unit
- Pflaster
- Composition
- Tela cum praeparatione (Panel 1): niccoli sulfas 0.16 mg, hydroxypropylcellulosum, alcoholes adipis lanae 0.81 mg, povidonum, neomycini sulfas 0.49 mg, povidonum, kalii dichromas 0.044 mg, povidonum, Cain-Mix: benzocainum 0.364 mg, cinchocaini hydrochloridum 0.073 mg, tetracaini hydrochloridum 0.073 mg, povidonum, Parfum-Mix: amylis cinnamaldehydum 0.015 mg, isoeugenolum 0.015 mg, cinnamaldehydum 0.034 mg, eugenolum 0.034 mg, alcohol cinnamylicus 0.054 mg, hydroxycitronellalum 0.054 mg, geraniolum 0.070 mg, evernia prunastri 0.070 mg, hydroxypropylcellulosum, betadexum, colophonium 0.97 mg, povidonum, E 320 0.011 mg, E 321 0.011 mg, Paraben-Mix: E 218 0.16 mg, E 214 0.16 mg, propylis parahydroxybenzoas 0.16 mg, butylis parahydroxybenzoas 0.16 mg, benzylis parahydroxybenzoas 0.16 mg, povidonum, balsamum peruvianum 0.65 mg, povidonum, ethylendiamini dihydrochloridum 0.041 mg, povidonum, cobalti dichloridum 0.016 mg, hydroxypropylcellulosum, polyesterum, ethyleni et vinylis acetatis polymerisatum, acrylic adhesive, pro praeparatione. Tela cum praeparatione (Panel 2): resina p-tert-butylphenoli formaldehydi 0.036 mg, hydroxypropylcellulosum, epoxy resina 0.041 mg, hydroxypropylcellulosum, Carba-Mix: diphenylguanidinum 0.068 mg, zinci diethyldithiocarbamas 0.068 mg, zinci dibutyldithiocarbamas 0.068 mg, hydroxypropylcellulosum, Schwarzgummi-Mix: isopropylphenyl-para-phenylendiaminum 0.010 mg, cyclohexylphenyl-para-phenylendiaminum 0.025 mg, diphenyl-para-phenylendiaminum 0.025 mg, povidonum, Methyl(chlor)isothiazolinon: methylchloroisothiazolinonum 0.0024 mg, methylisothiazolinonum 0.00081 mg, povidonum, quaternium-15 0.081 mg, hydroxypropylcellulosum, methyldibromoglutaronitrilum 0.0041 mg, povidonum, para-phenylendiaminum 0.065 mg, povidonum, formaldehydum 0.15 mg ut hydroxymethylis succinimidum, natrii carbonas, natrii hydrogenocarbonas, povidonum, Mercapto-Mix: morpholinylmercaptobenzothiazolum 0.020 mg, cyclohexylbenzothiazylis sulfenamidum 0.020 mg, dibenzothiazylis disulfidum 0.020 mg, povidonum, thiomersalum 0.0057 mg, povidonum, Thiuram-Mix: tetramethylthiuramum monosulfidum 0.0055 mg, thiramum 0.0055 mg, disulfiramum 0.0055 mg, dipentamethylenis thiurami disulfidum 0.0055 mg, povidonum, polyesterum, ethyleni et vinylis acetatis polymerisatum, acrylic adhesive, pro praeparatione. Tela cum praeparatione (Panel 3): diazolidinylureum 0.45 mg, povidonum, Quinolin-Mix: clioquinolum 0.08 mg, chlorquinaldolum 0.08 mg, povidonum, tixocortoli pivalas 0.0024 mg, povidonum, natrii aurothiosulfas dihydricus 0.061 mg, hydroxypropylcellulosum, imidazolidinylureum 0.49 mg, povidonum, budesonidum 0.0008 mg, povidonum, hydrocortisoni-17 butyras 0.016 mg, povidonum, mercaptobenzothiazolum 0.061 mg, povidonum, bacitracinum 0.49 mg, hydroxypropylcellulosum, parthenolidum 0.0024 mg, povidonum, caeruleum dispersatum 106 0.041 mg, povidonum, bronopolum 0.20 mg, povidonum, polyesterum, ethyleni et vinylis acetatis polymerisatum, acrylic adhesive, pro praeparatione.
Articles (1)
True Test, Pflaster
Pflaster
10 x 3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
TCPRA
|
0.45 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.036 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.81 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.08 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.08 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.044 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.068 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.061 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.364 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.073 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.01 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.073 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0008 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.015 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.016 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.015 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.061 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.00081 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.034 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.034 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.081 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.054 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.49 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.054 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.07 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0024 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.07 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.065 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.2 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.15 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.97 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | WIZUS |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.011 MG | Substance | HBESI |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.011 MG | Substance | HBESI |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.02 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.16 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0057 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.65 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.041 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.016 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
0.0055 MG | Substance | Wirkstoff (Principe actif) |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
|
TCPRA
|
- | Substance | HNIDK |
Authorization holder
Stallergenes AG
8305 Dietlikon
Authorization information
- Swissmedic authorization number
- 56688
- Drug name
- True Test, Pflaster
- Galenic form
- WIRSP
- ATC Code
- V04CL
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/09/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 14.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRUE TEST empl 10 x 3 pce
- Description (DE)
- TRUE TEST Pfl 10 x 3 Stk
- Market launch
- 26/07/2012
- Narcotic (BTM)
- No